Genome-wide Association Study to Predict Treatment Response for Molecular Targeted Therapy in Hepatocellular Carcinoma and Renal Cell Carcinoma

Share this content:
Genome-wide Association Study to Predict Treatment Response for Molecular Targeted Therapy in Hepatocellular Carcinoma and Renal Cell Carcinoma

Sponsors and Collaborators
Samsung Medical Center

Contact
mi yeon kwon, RN
+82-2-3410-1248
miyeon.kwon@samsung.com

Principal Investigator
Ho Yeong Lim, MD

ClinicalTrials.gov Identifier
NCT01482520

You must be a registered member of Renal and Urology News to post a comment.

Sign Up for Free e-newsletters